中华耳科学杂志
中華耳科學雜誌
중화이과학잡지
CHINESE JOURNAL OF OTOLOGY
2009年
3期
204-207
,共4页
耳鸣%中医治疗%耳聋左慈丸%松龄血脉康
耳鳴%中醫治療%耳聾左慈汍%鬆齡血脈康
이명%중의치료%이롱좌자환%송령혈맥강
Tinnitus%Traditional Chinese medicine treatment%Erlongzuoci Pill%Songlingxuemaikang Capsule
目的 采用随机、对照的临床研究方法观察耳聋左慈丸联合松龄血脉康治疗耳鸣的疗效.方法 60例40岁以上以耳鸣为主诉的门诊患者,排除客观性耳鸣、外耳及中耳疾病.随机分为2组,对照组给予耳聋左慈丸治疗,实验组给予耳聋左慈丸治疗的同时,加用松龄血脉康胶囊,用药时间为1月,停药后随访1月,评定疗效.结果 实验组痊愈4例、显效13例、有效8例、无效4例、失访1例,总有效率83.3%;对照组痊愈1例、显效10例、有效7例、无效12例,总有效率60.0%.2组总有效率比较P<0.05.实验组有效率显著高于对照组.2组均未出现药物不良反应.结论 耳聋左慈丸联合松龄血脉康临床上治疗主观性耳鸣较单用耳聋左慈丸有明显的优势,但还需大样本、多中心、随机对照的长期观察研究进一步验证确切疗效.
目的 採用隨機、對照的臨床研究方法觀察耳聾左慈汍聯閤鬆齡血脈康治療耳鳴的療效.方法 60例40歲以上以耳鳴為主訴的門診患者,排除客觀性耳鳴、外耳及中耳疾病.隨機分為2組,對照組給予耳聾左慈汍治療,實驗組給予耳聾左慈汍治療的同時,加用鬆齡血脈康膠囊,用藥時間為1月,停藥後隨訪1月,評定療效.結果 實驗組痊愈4例、顯效13例、有效8例、無效4例、失訪1例,總有效率83.3%;對照組痊愈1例、顯效10例、有效7例、無效12例,總有效率60.0%.2組總有效率比較P<0.05.實驗組有效率顯著高于對照組.2組均未齣現藥物不良反應.結論 耳聾左慈汍聯閤鬆齡血脈康臨床上治療主觀性耳鳴較單用耳聾左慈汍有明顯的優勢,但還需大樣本、多中心、隨機對照的長期觀察研究進一步驗證確切療效.
목적 채용수궤、대조적림상연구방법관찰이롱좌자환연합송령혈맥강치료이명적료효.방법 60례40세이상이이명위주소적문진환자,배제객관성이명、외이급중이질병.수궤분위2조,대조조급여이롱좌자환치료,실험조급여이롱좌자환치료적동시,가용송령혈맥강효낭,용약시간위1월,정약후수방1월,평정료효.결과 실험조전유4례、현효13례、유효8례、무효4례、실방1례,총유효솔83.3%;대조조전유1례、현효10례、유효7례、무효12례,총유효솔60.0%.2조총유효솔비교P<0.05.실험조유효솔현저고우대조조.2조균미출현약물불량반응.결론 이롱좌자환연합송령혈맥강림상상치료주관성이명교단용이롱좌자환유명현적우세,단환수대양본、다중심、수궤대조적장기관찰연구진일보험증학절료효.
Objective Use To study effects of Erlongzuoci Pill in combination with Songlingxuemaikang Capsule on tinnitus. Methods After ruling out objective tinnitus and outer or middle ear diseases, 60 patients complaining of tinnitus were randomized selected to be treated with either the Erlongzuoci Pill alone or with the Songlingxuemaikang Capsule in addition to the Erlongzuoci Pill. Patients were treated for 1 month and examined at 1 month follow-up after discontinua tion of treatment. Results Of the patients receiving both medictions, 4 reported complete resolution of tinnitus, 13 re ported marked improvement, 8 reported some improvement,,4 showed no improvement and 1 was lost to follow up, yielding an effective rate of 83.3%. Among those who received the Erlongzuoci Pill only, 1 was cured, 10 showed marked improve ment, 7 reported some improvement and 12 got no improvement, demonstrating an effective rate of 60.0% which is lower than those receiving both medications (P<0.05). There was no drug adverse reaction in either group. Conclusion Er longzuoci Pill combined with Songlingxuemaikang Capsule demonstrates improved treatment effects compared to Er longzuoci Pill alone in the treatment of subjective tinnitus. Large series of multicentre, randomized,and placebo-controlled long term studies are needed to confirm this observation.